Aneta Szudy‐Szczyrek

The Association of GSTT1, GSTM1, and TNF-α Polymorphisms With the Risk and Outcome in Multiple Myeloma

Szymon Zmorzyński, Sylwia Popek-Marciniec, Aneta Szudy‐Szczyrek et al. · Frontiers in Oncology · 2019 · 38 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

ACE Insertion/Deletion Polymorphism (rs4646994) Is Associated With the Increased Risk of Multiple Myeloma

Szymon Zmorzyński, Aneta Szudy‐Szczyrek, Sylwia Popek-Marciniec et al. · Frontiers in Oncology · 2019 · 36 citations · Full text

Medicine, Genetics, Hematology +15

Serum brain‐derived neurotrophic factor (BDNF) concentration predicts polyneuropathy and overall survival in multiple myeloma patients

Aneta Szudy‐Szczyrek, Radosław Mlak, Magdalena Bury‐Kamińska et al. · British Journal of Haematology · 2020 · 24 citations · Full text

Medicine, Neurology, Oncology +13

Neutrophil-to-Lymphocyte Ratio as a Factor Predicting Radiotherapy Induced Oral Mucositis in Head Neck Cancer Patients Treated with Radiotherapy

Iwona Homa‐Mlak, Anna Brzozowska, Radosław Mlak et al. · Journal of Clinical Medicine · 2021 · 24 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimen

Aneta Szudy‐Szczyrek, Radosław Mlak, Michał Mielnik et al. · Annals of Hematology · 2020 · 23 citations · Full text

Medicine, Hematology, Oncology +15